Hospital das Clínicas, Universidade de São Paulo - USP, São Paulo, SP, Brasil.
Hospital Alemão Oswaldo Cruz, São Paulo, SP, Brasil.
Int Braz J Urol. 2024 Mar-Apr;50(2):152-163. doi: 10.1590/S1677-5538.IBJU.2023.0626.
The aim of this study is to perform a high-quality meta-analysis using only randomized controlled trials (RCT) to better define the role of postoperative antibiotics in patients undergoing percutaneous nephrolithotomy (PCNL).
A literature search for RCTs in EMBASE, PubMed, and Web of Science up to May 2023 was conducted following the PICO framework: Population-adult patients who underwent PCNL; Intervention-postoperative antibiotic prophylaxis until nephrostomy tube withdrawal; Control-single dose of antibiotic during the induction of anesthesia; and Outcome-systemic inflammatory response syndrome (SIRS) or sepsis and fever after PCNL. The protocol was registered on the PROSPERO database (CRD42022361579). We calculated odds ratios (OR) and 95% confidence intervals (CI). A random-effects model was employed, and the alpha risk was defined as < 0.05.
Seven articles, encompassing a total of 629 patients, were included in the analysis. The outcome of SIRS or sepsis was extracted from six of the included studies, while the outcome of postoperative fever was extracted from four studies. The analysis revealed no statistical association between the use of postoperative antibiotic prophylaxis until nephrostomy tube withdrawal and the occurrence of SIRS/sepsis (OR 1.236, 95% CI 0.731 - 2.089, p=0.429) or fever (OR 2.049, 95% CI 0.790 - 5.316, p=0.140).
Our findings suggest that there is no benefit associated with the use of postoperative antibiotic prophylaxis until nephrostomy tube withdrawal in patients undergoing percutaneous nephrolithotomy (PCNL). We recommend that antibiotic prophylaxis should be administered only until the induction of anesthesia in PCNL.
本研究旨在通过仅使用随机对照试验(RCT)进行高质量的荟萃分析,以更好地确定经皮肾镜碎石取石术(PCNL)后抗生素的作用。
根据 PICO 框架,对 EMBASE、PubMed 和 Web of Science 中的 RCT 进行文献检索,直到 2023 年 5 月:人群-接受 PCNL 的成年患者;干预-术后抗生素预防治疗直至肾造瘘管拔出;对照-麻醉诱导时单次给予抗生素;结局-经皮肾镜碎石取石术后全身炎症反应综合征(SIRS)或败血症和发热。该方案在 PROSPERO 数据库(CRD42022361579)中进行了注册。我们计算了比值比(OR)和 95%置信区间(CI)。采用随机效应模型,alpha 风险定义为<0.05。
共纳入 7 篇文章,共计 629 例患者。其中 6 项研究提取了 SIRS 或败血症的结果,4 项研究提取了术后发热的结果。分析结果显示,术后抗生素预防治疗直至肾造瘘管拔出与 SIRS/败血症(OR 1.236,95%CI 0.731-2.089,p=0.429)或发热(OR 2.049,95%CI 0.790-5.316,p=0.140)的发生无统计学关联。
我们的研究结果表明,在接受经皮肾镜碎石取石术(PCNL)的患者中,术后直至肾造瘘管拔出使用抗生素预防治疗没有益处。我们建议仅在 PCNL 麻醉诱导时给予抗生素预防治疗。